Assembly of functionally integrated human forebrain spheroids

  • Nature volume 545, pages 5459 (04 May 2017)
  • doi:10.1038/nature22330
  • Download Citation


The development of the nervous system involves a coordinated succession of events including the migration of GABAergic (γ-aminobutyric-acid-releasing) neurons from ventral to dorsal forebrain and their integration into cortical circuits. However, these interregional interactions have not yet been modelled with human cells. Here we generate three-dimensional spheroids from human pluripotent stem cells that resemble either the dorsal or ventral forebrain and contain cortical glutamatergic or GABAergic neurons. These subdomain-specific forebrain spheroids can be assembled in vitro to recapitulate the saltatory migration of interneurons observed in the fetal forebrain. Using this system, we find that in Timothy syndrome—a neurodevelopmental disorder that is caused by mutations in the CaV1.2 calcium channel—interneurons display abnormal migratory saltations. We also show that after migration, interneurons functionally integrate with glutamatergic neurons to form a microphysiological system. We anticipate that this approach will be useful for studying neural development and disease, and for deriving spheroids that resemble other brain regions to assemble circuits in vitro.

  • Subscribe to Nature for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    & Interneuron cell types are fit to function. Nature 505, 318–326 (2014)

  2. 2.

    & The origin and specification of cortical interneurons. Nat. Rev. Neurosci. 7, 687–696 (2006)

  3. 3.

    , , , & The cellular and molecular landscapes of the developing human central nervous system. Neuron 89, 248–268 (2016)

  4. 4.

    , & Integration of GABAergic interneurons into cortical cell assemblies: lessons from embryos and adults. Neuron 79, 849–864 (2013)

  5. 5.

    & Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2, 255–267 (2003)

  6. 6.

    Interneuron dysfunction in psychiatric disorders. Nat. Rev. Neurosci. 13, 107–120 (2012)

  7. 7.

    & Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat. Rev. Genet. 15, 82–92 (2014)

  8. 8.

    , & Generating human neurons in vitro and using them to understand neuropsychiatric disease. Annu. Rev. Neurosci. 37, 479–501 (2014)

  9. 9.

    et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 12, 559–572 (2013)

  10. 10.

    et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 12, 573–586 (2013)

  11. 11.

    et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671–678 (2015)

  12. 12.

    , , & Structural and immunocytochemical differentiation of neurons in prenatal and postnatal human prefrontal cortex. Neuroembryology 1, 176–186 (2002)

  13. 13.

    , & Expression profiling. Combinatorial labeling of single cells for gene expression cytometry. Science 347, 1258367 (2015)

  14. 14.

    & Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008)

  15. 15.

    et al. Generation of Cre-transgenic mice using Dlx1/Dlx2 enhancers and their characterization in GABAergic interneurons. Mol. Cell. Neurosci. 40, 167–186 (2009)

  16. 16.

    et al. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet syndrome patients. eLife 5, e13073 (2016)

  17. 17.

    & KCC2 expression promotes the termination of cortical interneuron migration in a voltage-sensitive calcium-dependent manner. Neuron 62, 53–71 (2009)

  18. 18.

    , , & Ventricle-directed migration in the developing cerebral cortex. Nat. Neurosci. 5, 218–224 (2002)

  19. 19.

    , , , & Distinct cortical migrations from the medial and lateral ganglionic eminences. Development 128, 353–363 (2001)

  20. 20.

    , , , & Nucleokinesis in tangentially migrating neurons comprises two alternating phases: forward migration of the Golgi/centrosome associated with centrosome splitting and myosin contraction at the rear. J. Neurosci. 25, 5691–5699 (2005)

  21. 21.

    et al. CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 23, 5123–5130 (2003)

  22. 22.

    of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013)

  23. 23.

    Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014)

  24. 24.

    et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004)

  25. 25.

    et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl Acad. Sci. USA 102, 8089–8096 (2005)

  26. 26.

    et al. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 17, 1657–1662 (2011)

  27. 27.

    et al. Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. J. Biol. Chem. 285, 43–53 (2010)

  28. 28.

    & Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (Ca(V)1.2) calcium channels. Br. J. Pharmacol. 152, 386–395 (2007)

  29. 29.

    , , , & Topographical transcriptome mapping of the mouse medial ganglionic eminence by spatially resolved RNA-seq. Genome Biol. 15, 486 (2014)

  30. 30.

    , , & Gene expression in cortical interneuron precursors is prescient of their mature function. Cereb. Cortex 18, 2306–2317 (2008)

  31. 31.

    , , , & GRIP1 and 2 regulate activity-dependent AMPA receptor recycling via exocyst complex interactions. Proc. Natl Acad. Sci. USA 107, 19038–19043 (2010)

  32. 32.

    et al. Sensory experience regulates cortical inhibition by inducing IGF1 in VIP neurons. Nature 531, 371–375 (2016)

  33. 33.

    , & Circadian abnormalities in mouse models of Smith–Magenis syndrome: evidence for involvement of RAI1. Am. J. Med. Genet. A 161, 1561–1568 (2013)

  34. 34.

    et al. TCF4, schizophrenia, and Pitt–Hopkins syndrome. Schizophr. Bull. 36, 443–447 (2010)

  35. 35.

    et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013)

  36. 36.

    et al. Modeling human cortical development in vitro using induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 109, 12770–12775 (2012)

  37. 37.

    et al. Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell-derived neocortex. Proc. Natl Acad. Sci. USA 110, 20284–20289 (2013)

  38. 38.

    et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165, 1238–1254 (2016)

  39. 39.

    et al. Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons. Nat. Neurosci. 16, 201–209 (2013)

  40. 40.

    et al. Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. Genome Med. 6, 75 (2014)

  41. 41.

    et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230–234 (2011)

  42. 42.

    et al. A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics. eLife 4, e07103 (2015)

  43. 43.

    ., & Generation and assembly of forebrain spheroids from human pluripotent stem cells. Protoc. Exch. (2017)

  44. 44.

    et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat. Biotechnol. 34, 204–209 (2016)

  45. 45.

    et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37–53 (2016)

  46. 46.

    , & Ex utero electroporation and organotypic slice culture of mouse hippocampal tissue. J. Vis. Exp. (97), e52550 (2015)

  47. 47.

    & Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl Acad. Sci. USA 101, 16–22 (2004)

  48. 48.

    et al. Radial glia require PDGFD–PDGFRβ signalling in human but not mouse neocortex. Nature 515, 264–268 (2014)

  49. 49.

    et al. iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159, 896–910 (2014)

  50. 50.

    et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015)

  51. 51.

    & Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010)

  52. 52.

    et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat. Methods 10, 1096–1098 (2013)

  53. 53.

    et al. Accounting for technical noise in single-cell RNA-seq experiments. Nat. Methods 10, 1093–1095 (2013)

  54. 54.

    , , , & Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015)

  55. 55.

    , , , & Single-synapse analysis of a diverse synapse population: proteomic imaging methods and markers. Neuron 68, 639–653 (2010)

  56. 56.

    et al. The development of phasic and tonic inhibition in the rat visual cortex. Korean J. Physiol. Pharmacol. 14, 399–405 (2010)

Download references


We thank J. Y. Park, K. Sabatini, T. Khan, S. Yoon, H. Gai and L. Elahi at Stanford University, R.E. Dolmetsch at Novartis Institutes for Biomedical Research, and N. Bansal and J. Fan at BD Genomics for advice and support. This work was supported by grants from NIH/National Institute of Mental Health (NIMH) grants R01MH100900 and R01MH100900-02S1, NIMH BRAINS Award R01MH107800, the California Institute of Regenerative Medicine (CIRM), the MQ Fellow Award, the Donald E. and Delia B. Baxter Foundation Faculty Award, the Kwan Research Fund and Stanford Start-up Funds (to S.P.P.), Child Research Health Institute Postdoctoral Fellowship (CHRI) (to F.B., N.H.), Walter V. and Idun Berry Postdoctoral Fellowship (to J.A.) and the Stanford Medicine Dean’s Fellowship (to F.B., J.A., N.H.), the American Epilepsy Society and Wishes for Elliott Foundation Fellowship (to C.D.M.), NIH 5P01HG00020526 (to L.M.S.), the UCSF Program for Breakthrough Biomedical Research and Sandler Foundation (to G.P.).

Author information

Author notes

    • Fikri Birey
    • , Jimena Andersen
    •  & Christopher D. Makinson

    These authors contributed equally to this work.


  1. Department of Psychiatry and Behavioral Sciences, Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Stanford, California 94305, USA

    • Fikri Birey
    • , Jimena Andersen
    • , Nina Huber
    • , Nicholas Thom
    • , Nancy A. O’Rourke
    • , Joachim Hallmayer
    •  & Sergiu P. Paşca
  2. Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA

    • Christopher D. Makinson
    •  & John R. Huguenard
  3. Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA

    • Saiful Islam
    • , Wu Wei
    •  & Lars M. Steinmetz
  4. Stanford Genome Technology Center, Stanford University, Palo Alto, California 94304, USA

    • Wu Wei
    •  & Lars M. Steinmetz
  5. BD Genomics, Menlo Park, California 94025, USA

    • H. Christina Fan
    •  & Kimberly R. Cordes Metzler
  6. Department of Biochemistry and Biophysics, The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, California 94143, USA

    • Georgia Panagiotakos
  7. European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany

    • Lars M. Steinmetz
  8. Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA

    • Jonathan A. Bernstein


  1. Search for Fikri Birey in:

  2. Search for Jimena Andersen in:

  3. Search for Christopher D. Makinson in:

  4. Search for Saiful Islam in:

  5. Search for Wu Wei in:

  6. Search for Nina Huber in:

  7. Search for H. Christina Fan in:

  8. Search for Kimberly R. Cordes Metzler in:

  9. Search for Georgia Panagiotakos in:

  10. Search for Nicholas Thom in:

  11. Search for Nancy A. O’Rourke in:

  12. Search for Lars M. Steinmetz in:

  13. Search for Jonathan A. Bernstein in:

  14. Search for Joachim Hallmayer in:

  15. Search for John R. Huguenard in:

  16. Search for Sergiu P. Paşca in:


F.B. and J.A. developed the differentiation platform and assays. C.D.M. and J.R.H. designed, conducted and analysed the electrophysiological experiments. F.B., J.A., N.H. and N.T. contributed to neural differentiation, live cell imaging experiments and analysis. F.B. and J.A. were able to replicate the differentiation and spheroid assembly independently. S.I., W.W., H.C.F., K.R.C.M. and L.M.S. contributed to the single-cell experiments. N.A.O. performed the array tomography. J.A.B. and J.H. recruited and characterized the subjects. G.P., J.A. and F.B. performed or analysed the electroporation experiments. F.B, J.A. and S.P.P. conceived the project, designed experiments and wrote the paper with input from all authors. S.P.P. supervised all aspects of the work.

Competing interests

Stanford University has filed a provisional patent application that covers the generation of region-specific neural spheroids and their assembly for studying human development and disease (US patent application number 62/477,858). H.C.F. and K.R.C.M. were employees of BD Genomics during this study.

Corresponding author

Correspondence to Sergiu P. Paşca.

Reviewer Information Nature thanks G. Fishell, A. Goffinet and B. Treutlein for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    This file contains Supplementary Tables 1-5.


  1. 1.

    Live imaging (14.2 hrs) showing migration of Dlx2i1/2b::eGFP+ cells in fused hSS-hCS (day 12 after fusion).

    hCS is located in the upper side part of the fused spheroids. Yellow arrowheads point to cells undergoing saltatory migration steps.

  2. 2.

    Live imaging showing migration of Dlx2i1/2b::eGFP+ cells in a hSS plated on a coverslip (example #1: 22.7 hrs; example #1: 6.7 hrs).

    Arrows indicate representative Dlx2i1/2b::eGFP+ cells.

  3. 3.

    Live imaging (15.2 hrs) showing ventricle directed migration of Dlx2i1/2b::eGFP+ cells in fused hSS-hCS

    A VZ-like region in the hCS has been identified by bright field microscopy and indicated with two concentrical circles.

  4. 4.

    Live imaging (18.2 hrs; low magnification) showing migration of Dlx2i1/2b::eGFP+ cells in slices of human fetal forebrain at GW20

    Human fetal slices were labeled with the reporter 5–6 days before imaging.

  5. 5.

    Live imaging (18.9 hrs) showing examples of migrating Dlx2i1/2b::eGFP+ cells in slices of human fetal forebrain at GW18 versus fused hSS-hCS

    Human fetal slices were labeled with the reporter 5–6 days before imaging.

  6. 6.

    Live imaging showing migration of Dlx2i1/2b::eGFP+ cells in fused hSS-hCS before (9.6 hrs) and during exposure to the CXCR4 receptor antagonist AMD3100 (24.4 hrs total imaging time)

    Live imaging showing migration of Dlx2i1/2b::eGFP+ cells in fused hSS-hCS before (9.6 hrs) and during exposure to the CXCR4 receptor antagonist AMD3100 (24.4 hrs total imaging time).

  7. 7.

    Live imaging (4.6 hrs) showing migration of Dlx2i1/2b::eGFP+ cells in fused hSS-hCS derived from TS subject (lower panel) and a control subject (upper panel)

    Live imaging (4.6 hrs) showing migration of Dlx2i1/2b::eGFP+ cells in fused hSS-hCS derived from TS subject (lower panel) and a control subject (upper panel).


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.